189 related articles for article (PubMed ID: 20206059)
1. [New international guidelines on pulmonary hypertension].
Dinh-Xuan AT; Duong-Quy S
Rev Mal Respir; 2010 Feb; 27(2):110-1. PubMed ID: 20206059
[No Abstract] [Full Text] [Related]
2. Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension.
Archer SL; Michelakis ED
N Engl J Med; 2009 Nov; 361(19):1864-71. PubMed ID: 19890129
[No Abstract] [Full Text] [Related]
3. [Pulmonary arterial hypertension. New therapeutic principles improve treatment of a rare condition].
Ekmehag B
Lakartidningen; 2009 Aug 19-25; 106(34):2057-61. PubMed ID: 19769147
[No Abstract] [Full Text] [Related]
4. Phosphodiesterase inhibitors for pulmonary hypertension.
Galiè N; Rubin LJ; Simonneau G
N Engl J Med; 2010 Feb; 362(6):559-60; author reply 560. PubMed ID: 20175298
[No Abstract] [Full Text] [Related]
5. [Update: Current clinical developments in pulmonary hypertension].
Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological treatment of pulmonary hypertension in patients with congenital heart disease].
Miera O; Farahwaschy B; Schulze-Neick I; Berger F
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S209-11. PubMed ID: 18814099
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary arterial hypertension--a rare form of pulmonary hypertension].
Schenk M
Dtsch Med Wochenschr; 2010 May; 135(21):p21. PubMed ID: 20509110
[No Abstract] [Full Text] [Related]
8. [Pulmonary hypertension--classification and treatment: new guidelines].
Bendayan D; Kramer MR
Harefuah; 2005 Mar; 144(3):206-10, 229. PubMed ID: 15844462
[TBL] [Abstract][Full Text] [Related]
9. [Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].
Montani D; Humbert M
Rev Mal Respir; 2010 Feb; 27(2):103-5. PubMed ID: 20206056
[No Abstract] [Full Text] [Related]
10. Phosphodiesterase inhibitors for pulmonary hypertension.
Bergot E; Magnier R; Zalcman G
N Engl J Med; 2010 Feb; 362(6):559; author reply 560. PubMed ID: 20147727
[No Abstract] [Full Text] [Related]
11. [Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010].
Ghofrani HA; Distler O; Gerhardt F; Gorenflo M; Grünig E; Haefeli WE; Held M; Hoeper MM; Kähler CM; Kaemmerer H; Klose H; Köllner V; Kopp B; Mebus S; Meyer A; Miera O; Pittrow D; Riemekasten G; Rosenkranz S; Schranz D; Voswinckel R; Olschewski H;
Dtsch Med Wochenschr; 2010 Oct; 135 Suppl 3():S87-101. PubMed ID: 20862625
[TBL] [Abstract][Full Text] [Related]
12. Preoperative administration of PDE-5 Inhibitors.
Edwards AF; Roy RC
J Clin Anesth; 2009 Mar; 21(2):149; author reply 149-50. PubMed ID: 19329023
[No Abstract] [Full Text] [Related]
13. Pulmonary hypertension in older children: new approaches and therapies.
Abman SH
Paediatr Respir Rev; 2006; 7 Suppl 1():S177-9. PubMed ID: 16798555
[No Abstract] [Full Text] [Related]
14. [Pulmonary arterial hypertension. Part II: Medical and surgical treatment].
Manes A; Marinelli A; Palazzini M; Negro L; Leci E; Gambetti S; Bachetti C; Beciani E; Conficoni E; Branzi A; Galiè N
G Ital Cardiol (Rome); 2009 Jun; 10(6):366-81. PubMed ID: 19603608
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary arterial hypertension].
Reichenberger F
MMW Fortschr Med; 2009 Sep; 151(39):47-9. PubMed ID: 19831197
[No Abstract] [Full Text] [Related]
17. Phosphodiesterase type 5 inhibition: a support of the left ventricular assist device bridge to transplant.
Semigran MJ
Circ Heart Fail; 2008 Nov; 1(4):211-2. PubMed ID: 19808293
[No Abstract] [Full Text] [Related]
18. [Current treatment of pulmonary arterial hypertension].
Preston IR
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2095-6. PubMed ID: 20058609
[No Abstract] [Full Text] [Related]
19. Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.
Stehlik J; Movsesian MA
J Card Fail; 2009 Feb; 15(1):31-4. PubMed ID: 19181291
[TBL] [Abstract][Full Text] [Related]
20. Sarcoidosis-associated pulmonary hypertension: assessment and management.
Palmero V; Sulica R
Semin Respir Crit Care Med; 2010 Aug; 31(4):494-500. PubMed ID: 20665399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
